Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Dec 21, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS INC | NASDAQ | Biotechnology | A | $52.88B | $400.23 | 1.06% | $151.92M | 1,291.06x | 19.74 | United States | 45 |
| ONC | BEONE MEDICINES LTD | NASDAQ | Biotechnology | A | $35.01B | $316.05 | 2.94% | $318.03M | 6,321.00x | 0.85 | Cayman Islands | 53 |
| FIX | COMFORT SYSTEMS USA INC | NYSE | Engineering & Construction | A | $33.18B | $940.74 | 2.42% | $1.21B | 39.74x | 1.59 | United States | 61 |
| NVT | NVENT ELECTRIC PLC | NYSE | Electrical Equipment & Parts | A | $16.38B | $101.54 | 3.32% | $1.08B | 27.67x | 0.86 | United Kingdom | 42 |
| NBIX | NEUROCRINE BIOSCIENCES INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $14.46B | $145.00 | 2.23% | $679.20M | 33.64x | 0.42 | United States | 55 |
| VTRS | VIATRIS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $13.74B | $11.93 | -0.08% | -$598.90M | -3.86x | 1.49 | United States | 30 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | NASDAQ | Biotechnology | A | $10.15B | $166.99 | 0.60% | $182.64M | -27.88x | 1.87 | Ireland | 16 |
| SGHC | SUPER GROUP (SGHC) LTD | NYSE | Gambling | A | $6.01B | $11.89 | -0.17% | N/A | 23.88x | 0.60 | Guernsey | 35 |
| GTES | GATES INDUSTRIAL CORP PLC | NYSE | Specialty Industrial Machinery | A | $5.58B | $21.61 | 0.79% | $672.10M | 23.49x | 1.02 | United States | 37 |
| MIRM | MIRUM PHARMACEUTICALS INC | NASDAQ | Biotechnology | A | $4.00B | $77.74 | 10.61% | -$592.00k | -91.46x | 1.69 | United States | 26 |
| UGP | ULTRAPAR HOLDINGS INC | NYSE | Oil & Gas Refining & Marketing | A | $3.98B | $3.68 | 0.00% | $1.18B | 9.97x | N/A | Brazil | 31 |
| MLCO | MELCO RESORTS & ENTERTAINMENT LTD | NASDAQ | Resorts & Casinos | A | $3.40B | $7.99 | 1.27% | N/A | 29.59x | -6.91 | Hong Kong | 30 |
| SPNT | SIRIUSPOINT LTD | NYSE | Insurance - Reinsurance | A | $2.58B | $22.10 | 0.27% | $339.10M | 13.31x | 4.64 | Bermuda | 28 |
| HCI | HCI GROUP INC | NYSE | Insurance - Property & Casualty | A | $2.46B | $189.94 | 0.21% | $301.16M | 11.00x | 1.82 | United States | 52 |
| EXTR | EXTREME NETWORKS INC | NASDAQ | Communication Equipment | A | $2.25B | $16.85 | 0.30% | $65.83M | 240.71x | 15.82 | United States | 34 |
| ANIP | ANI PHARMACEUTICALS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $1.86B | $82.85 | 0.02% | $165.21M | 48.45x | 1.78 | United States | 48 |
| BLBD | BLUE BIRD CORP | NASDAQ | Auto Manufacturers | A | $1.64B | $51.72 | 0.43% | $194.43M | 12.90x | 1.45 | United States | 52 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | A | $1.56B | $7.41 | 1.65% | $83.87M | -148.20x | -2.15 | United States | 17 |
| DNOW | DNOW INC | NYSE | Oil & Gas Equipment & Services | A | $1.44B | $13.69 | 1.86% | $165.00M | 15.38x | 0.40 | United States | 39 |
| ANAB | ANAPTYSBIO INC | NASDAQ | Biotechnology | A | $1.36B | $49.08 | 3.26% | -$82.14M | -17.91x | -13.00 | United States | 15 |
| DFIN | DONNELLEY FINANCIAL SOLUTIONS INC | NYSE | Capital Markets | A | $1.22B | $45.99 | -1.08% | $119.00M | 41.43x | 0.93 | United States | 38 |
| NUTX | NUTEX HEALTH INC | NASDAQ | Health Information Services | A | $1.22B | $171.93 | 3.05% | $227.40M | 8.11x | 1.66 | United States | 54 |
| TBLA | TABOOLACOM LTD | NASDAQ | Internet Content & Information | A | $1.16B | $4.01 | -0.50% | $137.29M | 50.13x | 0.68 | United States | 41 |
| CRTO | CRITEO SA | NASDAQ | Advertising Agencies | A | $1.02B | $19.50 | -1.61% | $219.28M | 6.25x | 0.79 | France | 51 |
| TBPH | THERAVANCE BIOPHARMA INC | NASDAQ | Biotechnology | A | $952.13M | $18.79 | 3.36% | $55.37M | 32.40x | 0.79 | Cayman Islands | 37 |
| ORGO | ORGANOGENESIS HOLDINGS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $710.71M | $5.60 | -2.95% | $18.04M | -46.67x | 0.49 | United States | 20 |
| BWMX | BETTERWARE DE MEXICO SAPI DE CV | NYSE | Specialty Retail | A | $514.60M | $13.79 | -0.14% | $145.14M | N/A | 6.80 | Mexico | 45 |
| VREX | VAREX IMAGING CORP | NASDAQ | Medical Devices | A | $512.49M | $12.29 | -0.32% | -$1.00M | -7.23x | 1.31 | United States | 24 |
| LE | LANDS' END INC | NASDAQ | Apparel Retail | A | $456.74M | $14.95 | -1.77% | $86.84M | 40.41x | 2.69 | United States | 32 |
| EGHT | 8X8 INC | NASDAQ | Software - Application | A | $288.37M | $2.08 | -1.89% | $51.06M | -52.00x | 4.04 | United States | 12 |
| OPRX | OPTIMIZERX CORP | NASDAQ | Health Information Services | A | $251.84M | $13.51 | -0.66% | $11.65M | N/A | 0.39 | United States | 26 |
| ELMD | ELECTROMED INC | NYSEMKT | Medical Devices | A | $238.71M | $28.62 | -4.38% | $12.05M | 29.51x | 0.20 | United States | 54 |
| LTRX | LANTRONIX INC | NASDAQ | Communication Equipment | A | $219.23M | $5.57 | 1.46% | -$5.00M | -21.42x | 0.61 | United States | 17 |
| CXDO | CREXENDO INC | NASDAQ | Telecom Services | A | $212.97M | $6.93 | 0.14% | $7.94M | 46.20x | 0.24 | United States | 42 |
| INFU | INFUSYSTEM HOLDINGS INC | NYSEMKT | Medical Instruments & Supplies | A | $187.09M | $9.20 | -3.36% | $24.16M | 35.38x | 0.78 | United States | 42 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.